';
Tags Posts tagged with "DDAP"

DDAP

Photo by Markus Winkler on Unsplash

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) notified single county authorities (SCA) that it will continue to distribute federal COVID-related grant funding to SCAs while the US District Court considers a 23-state lawsuit seeking an emergency temporary restraining order against US Health and Human Services Secretary Robert F. Kennedy Jr. for abruptly terminating COVID-grant funds that were appropriated for use for states until September 30, 2025. Those grant funds include a supplemental to the Substance Use Disorder Block Grant. The lawsuit was filed on April 1.

Though not confirmed, media reports suggest the termination of grants could cost the Pennsylvania Department of Health $301 million, along with an additional $28 million or more hit against DDAP.

DDAP had been using these grant funds to expand testing and provide resources for COVID; support providers and help meet local needs during the pandemic; and expand the substance use disorder prevention, intervention, treatment, and recovery support services continuum, including various evidence-based services and supports for individuals, families, and communities.

Governor Shapiro and Pennsylvania are listed along with 22 other plaintiffs in a lawsuit filed in US District Court in Rhode Island, requesting an emergency temporary restraining order against US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. for abruptly terminating COVID-grant funds, including a supplemental to the Substance Use Disorder Block Grant, that were appropriated for use for states until September 30, 2025.

Though not confirmed, media reports suggest the termination of grants could cost the Pennsylvania Department of Health $301 million, along with an additional $28 million or more hit against the Pennsylvania Department of Drug and Alcohol Programs (DDAP).

DDAP had been using these grant funds to expand testing and provide resources for COVID; support providers and help meet local needs during the pandemic; and expand the substance use disorder prevention, intervention, treatment, and recovery support services continuum, including various evidence-based services and supports for individuals, families, and communities.

DDAP is examining its options to maintain the full array of services offered by single county authorities and their providers to ensure Pennsylvanians continue to receive the lifesaving supports they need.

The factual allegations and legal background in the lawsuit state that during the COVID-19 pandemic, Congress appropriated substantial funds to strengthen public health programs that were not tied to the duration of the public health emergency. HHS and Congress continued to make these public health funds available after the end of the pandemic.

On Monday, March 24, with no advance notice, HHS abruptly terminated $11 billion in grants and cooperation agreements funded by appropriations from COVID-related laws. States were notified through letters from the Substance Abuse and Mental Health Administration (SAMHSA). The letters indicated the grants were issued for a limited purpose: to ameliorate the effects of the pandemic. The end of the pandemic provides cause to terminate COVID-related grants. Now that the pandemic is over, the grants are no longer necessary.

The lawsuit goes on to state the terminations have caused and will continue to cause irreparable harm and asks the court to vacate and set aside the termination of the funding and any other further actions taken by US HHS to implement or enforce them, among other requests.

Pennsylvania’s single county authorities (SCA), in collaboration with the Department of Drug and Alcohol Programs (DDAP), developed a new rate-setting package (i.e., XYZ Package) for residential providers to submit cost-based rate requests for Fiscal Year 2025/26.

The deadline to submit the rate package has been extended to Monday, March 24. This change is reflected in the package itself, which, along with a training video for how to complete the new package, is available on the PACDAA website.

The Department of Drug and Alcohol Programs (DDAP) today announced an investment of more than $2 million in grant funding for five Pennsylvania organizations to help improve Pennsylvanians’ access to substance use disorder (SUD) recovery houses that are licensed through DDAP.

Funding for these grants is provided from the more than $1 billion in funding Pennsylvania continues to receive from a large national opioid settlement with three distributors and one manufacturer.

DDAP is awarding five grants of up to $500,000 each to the following community-based organizations:

  • The Bridge Foundation: Philadelphia
  • The Worx!: Allegheny County
  • Sage’s Army: Allegheny, Westmorland, Fayette, and Washington counties
  • Westmoreland Community Action: Westmoreland, Fayette, Washington, Somerset, Bedford, Blair, Cambria, Greene, Lawrence, Butler, Armstrong, Indiana, Clearfield, Jefferson, Clarion, Mercer, Venango, Forest, Elk, McKean, and Crawford counties
  • Life Changing Pathways: Adams and York counties

The organizations are charged with leading initiatives to link individuals with opioid use disorder and any co-occurring SUD or mental health condition to DDAP-licensed recovery houses. They must also ensure these individuals have access to case management and peer support services while residing in a recovery house as well as access to financial assistance for those who are not able to pay the full cost of residing in a recovery house. In addition, all five grantees must have a plan to increase services to underserved populations and have a training plan to ensure staff are well-prepared to serve them.

Currently, there are about 400 DDAP-licensed recovery houses across the commonwealth. The purpose of the licensure program is to help empower sustained recovery for individuals with SUD by ensuring a network of safe drug and alcohol recovery houses. Individuals can find a listing of licensed recovery houses on DDAP’s website.

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) will host a webinar at 10:00 am on Monday, March 3, to discuss the changes to 42 CFR Part 8 and their real-world implications in treatment settings. The interactive session will feature Dr. Sarah Kawasaki and Elizabeth Ward, both from the Pennsylvania Psychiatric Institute’s Advancement in Recovery Opioid Treatment Program.

Add the meeting to your calendar.

Email DDAP to receive calendar invitations to upcoming webinars, which are held the first Monday of every month.

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) is hosting two upcoming Clinical Supervision Trainings (CST). These in-person trainings will build on the information provided in the online training and provide participants with the opportunity to practice their clinical supervision skills. Participants will also be provided with tools to assist in assessing and working with their supervisees.

The in-person trainings are being held at:

  • Allegheny County Single County Authority, 1 Smithfield St, Pittsburgh
    Monday, March 17 – Friday, March 21
  • Pine Barn Inn, 43 Pine Barn Pl, Danville
    Monday, April 21 – Friday, April 25

Trainings are from 9:00 am – 4:00 pm each day, and there is a $300 fee to attend. Registration is limited and will be processed in the order registrations are received. Those interested in the training can register on the Training Management System website. Email DDAP’s Training inbox with any questions.

The remainder of the 2025 CST dates and regions are listed below. Once locations are confirmed, they will be updated in DDAP’s Training Management System (TMS), offering a variety of in-person and virtual training to maintain your skills and fulfill requirements.

  • Southeast Region: Monday, May 12 – Friday, May 16
  • Northwest Region: Monday, June 9 – Friday, June 13
  • Northeast Region: Monday, August 25 – Friday, August 29
  • Southcentral Region: Monday, September 15 – Friday, September 19
  • Southwest Region: Monday, October 27 – Friday, October 31
  • Southeast Region: Monday, November 3 – Friday, November 7

DDAP has approved additional options for completing this requirement for those unable to attend an event but in need of training to fulfill licensing regulation requirements.

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) announced a joint initiative with Carlow and Waynesburg Universities to address the shortage of qualified addiction professionals within Pennsylvania’s behavioral health workforce.

Funded by DDAP, this pilot program will focus on the recruitment and retention of behavioral health professionals by providing financial assistance for participating students’ educational expenses. At its core, this initiative is designed to strengthen the substance use disorder (SUD) workforce pipeline by financially supporting master’s-level students at Carlow and Waynesburg Universities. Through the DDAP funding, both universities will offer tuition assistance, a stipend during the students’ practicum/internship with a community-based treatment provider, and additional SUD-related training offered by DDAP for students who qualify under each university’s respective programs.

Read the full press release.

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) today issued Licensing Alert 08-2024 to detail the steps for SUD treatment providers to obtain a telehealth-only license from the department.

These DDAP-licensed telehealth-only providers may provide intake, evaluation, and referral, as well as outpatient or partial hospitalization services, via telehealth only without a physical plant location in Pennsylvania to individuals who are located in the commonwealth as long as the provider complies with all applicable federal, state, and local laws. Any DDAP-licensed provider can also provide some telehealth services as an option to in-person treatment. However, only a telehealth-only provider may provide 100 percent of its treatment services via telehealth.

DDAP will not require the provider to maintain a physical location in Pennsylvania. DDAP also will grant all telehealth-only providers an exception to § 709.11(b) regarding the requirement to conduct an onsite inspection for the renewal of a license as part of licensure.

Licensing Alert 08-2024 applies only to DDAP licensure. Providers that are considering applying for a telehealth-only license should consult their public and private insurance payers to confirm whether they will meet conditions for network enrollment and payment, as DDAP cannot guarantee a DDAP-licensed telehealth-only provider funding or a contract.

The full licensing alert provides additional information, including how to apply for the license.

Contact RCPA SUD Treatment Services Policy Director Jason Snyder with any questions.

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) announced the availability of $2.5 million in grant funding for community-based organizations and public health programs to help improve Pennsylvanians’ access to existing substance use disorder (SUD) recovery houses that are licensed through DDAP.

Funding for these grants is provided from opioid settlement funding that was appropriated to DDAP by the General Assembly, which was the result of a multistate investigation of opioid manufacturers and distributors spearheaded by then-Attorney General Josh Shapiro that led to settlement agreements worth billions of dollars. That money is to be invested in opioid remediation programs and initiatives.

Read the full press release here.

Please reach out to RCPA SUD Policy Director Jason Snyder with any questions.